Justin Oldham
Clinical Associate Professor of Internal Medicine
1150 W. Medical Center Drive MSRBIII
Ann Arbor
Michigan, 48109 United States
[email protected]

Available to mentor
Justin Oldham
Clinical Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • Fellowship
      University of Chicago, Chicago, 2016
    • Residency
      University of California at Davis, USA, 2009
    • M.S.
      University of Chicago, United States, 2016
    • M.D.
      University of Colorado, United States, 2006
    • B.A.
      University of Colorado, United States, 2002
    • PhD
      University of Michigan Medical School, Ann Arbor
    Center Memberships
    • Center Member
      Precision Health Initiative
    Recent Publications See All Publications
    • Preprint
      Rare variants and survival of patients with idiopathic pulmonary fibrosis.
      Alonso-Gonzalez A, Jáspez D, Lorenzo-Salazar JM, Ma S-F, Strickland E, Mychaleckyj J, Kim JS, Huang Y, Adegunsoye A, Oldham JM, Steward I, Molyneaux PL, Maher TM, Wain LV, Allen RJ, Jenkins RG, Kropski JA, Yaspan B, Blackwell TS, Zhang D, Garcia CK, Martinez FJ, Noth I, Flores C. 2024 Oct 15; DOI:10.1101/2024.10.12.24315151
      PMID: 39484282
    • Journal Article
      Inhibition of MARCKS phosphorylation attenuates of dendritic cell migration in a murine model of acute asthma.
      Lee C-C, Chen C-H, Kenyon NJ, Wang C-N, Tsai H-C, Chiu C-L, Chen Y, Forteza RM, Wu R. Eur J Pharmacol, 2024 Oct 5; 980: 176867 DOI:10.1016/j.ejphar.2024.176867
      PMID: 39111683
    • Journal Article
      Competing Causes of Death in Idiopathic Pulmonary Fibrosis.
      Thenappan A, Maher TM, Yazbeck L, Jenkins RG, Johnson SR, Stewart I, Oldham JM, Molyneaux PL. Am J Respir Crit Care Med, 2024 Oct 1; 210 (7): 938 - 940. DOI:10.1164/rccm.202403-0595RL
      PMID: 39012209
    • Proceeding / Abstract / Poster
      Baseline characteristics of patients enrolled in the FIBRONEER-ILD trial of nerandomilast (BI 1015550)
      Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold A-M, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Coeck C, Schlosser A, Wachtlin D, Martinez FJ. 2024 Sep 14; pa671 DOI:10.1183/13993003.congress-2024.pa671
    • Proceeding / Abstract / Poster
      Design of the FIBRONEER-ON open-label extension trial of nerandomilast (BI 1015550)
      Wuyts WA, Richeldi L, Assassi S, Azuma A, Cottin V, Hoffmann-Vold A-M, Kreuter M, Oldham JM, Martinez FJ, Valenzuela C, Wijsenbeek MS, Kanakapura M, James A, Drzewuski C, Coeck C, Maher TM. 2024 Sep 14; pa672 DOI:10.1183/13993003.congress-2024.pa672
    • Journal Article
      Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis.
      Pugashetti JV, Kim JS, Bose S, Adegunsoye A, Linderholm AL, Chen C-H, Strek ME, Flaherty KR, Murray S, Newton CA, Alqalyoobi S, Ma S-F, Mychaleckyj JC, Bowler RP, Han MK, Curtis JL, Martinez FJ, Smith JA, Noth I, Oldham JM. Am J Respir Crit Care Med, 2024 Sep 1; 210 (5): 639 - 647. DOI:10.1164/rccm.202310-1887OC
      PMID: 38843133
    • Journal Article
      Biomarkers Unveil Insights into Pathology of Transitional Epithelial States in Pulmonary Fibrosis.
      Ting C, Konopka K, Benedeck RE, Riches DWH, Redente EF, Oldham JM, Zemans RL. Am J Respir Crit Care Med, 2024 Sep 1; 210 (5): 687 - 690. DOI:10.1164/rccm.202310-1839LE
      PMID: 38889340
    • Journal Article
      Transcriptome-Wide Association Study of Idiopathic Pulmonary Fibrosis Survival Identifies PTPN9 and SNRPB2.
      Hu X, Kim JS, Saferali A, Huang Y, Ma S-F, Bingham GC, Bonham CA, Flores C, Castaldi P, Hersh CP, Cho MH, IPF Survival GWAS Consortium , Noth I, Manichaikul A. Am J Respir Crit Care Med, 2024 Sep 1; 210 (5): 683 - 686. DOI:10.1164/rccm.202310-1741LE
      PMID: 38626378